Survival of diffuse astrocytic glioma, IDH1/2 wildtype, with molecular features of glioblastoma, WHO grade IV: a confirmation of the cIMPACT-NOW criteria

Mircea Tesileanu; L Dirven; Maarten Wijnenga; JAF Koekkoek; Arnaud Vincent; Erik jan Dubbink; Peggy Atmodimedjo; J.M. Kros; SG van Duinen; Marion Smits; MJ Taphoorn; Pim French; Martin van den Bent

doi:10.1093/neuonc/noz200

Survival of diffuse astrocytic glioma, IDH1/2 wildtype, with molecular features of glioblastoma, WHO grade IV: a confirmation of the cIMPACT-NOW criteria

Mircea Tesileanu, L Dirven, Maarten Wijnenga, JAF Koekkoek, Arnaud Vincent, Erik jan Dubbink, Peggy Atmodimedjo, J.M. Kros, SG van Duinen, Marion Smits, MJ Taphoorn, Pim French, Martin van den Bent

Research output: Contribution to journal › Article › Academic › peer-review

56 Citations (Scopus)

2 Downloads (Pure)

Original language	English
Pages (from-to)	515-523
Number of pages	9
Journal	Neuro-Oncology
Volume	22
Issue number	4
DOIs	https://doi.org/10.1093/neuonc/noz200
Publication status	Published - 2020

Access to Document

10.1093/neuonc/noz200

Repub_126358.pdfFinal published version, 607 KB

Cite this

Tesileanu, M., Dirven, L., Wijnenga, M., Koekkoek, JAF., Vincent, A., Dubbink, E. J., Atmodimedjo, P., Kros, J. M., van Duinen, SG., Smits, M., Taphoorn, MJ., French, P., & van den Bent, M. (2020). Survival of diffuse astrocytic glioma, IDH1/2 wildtype, with molecular features of glioblastoma, WHO grade IV: a confirmation of the cIMPACT-NOW criteria. Neuro-Oncology, 22(4), 515-523. https://doi.org/10.1093/neuonc/noz200

Tesileanu, Mircea ; Dirven, L ; Wijnenga, Maarten ; Koekkoek, JAF ; Vincent, Arnaud ; Dubbink, Erik jan ; Atmodimedjo, Peggy ; Kros, J.M. ; van Duinen, SG ; Smits, Marion ; Taphoorn, MJ ; French, Pim ; van den Bent, Martin. / Survival of diffuse astrocytic glioma, IDH1/2 wildtype, with molecular features of glioblastoma, WHO grade IV: a confirmation of the cIMPACT-NOW criteria. In: Neuro-Oncology. 2020 ; Vol. 22, No. 4. pp. 515-523.

@article{c247c3946dd84da0b9c625f5f6b67859,

title = "Survival of diffuse astrocytic glioma, IDH1/2 wildtype, with molecular features of glioblastoma, WHO grade IV: a confirmation of the cIMPACT-NOW criteria",

author = "Mircea Tesileanu and L Dirven and Maarten Wijnenga and JAF Koekkoek and Arnaud Vincent and Dubbink, {Erik jan} and Peggy Atmodimedjo and J.M. Kros and {van Duinen}, SG and Marion Smits and MJ Taphoorn and Pim French and {van den Bent}, Martin",

year = "2020",

doi = "10.1093/neuonc/noz200",

language = "English",

volume = "22",

pages = "515--523",

journal = "Neuro-Oncology",

issn = "1522-8517",

publisher = "Oxford University Press",

number = "4",

}

Tesileanu, M, Dirven, L, Wijnenga, M, Koekkoek, JAF, Vincent, A , Dubbink, EJ , Atmodimedjo, P , Kros, JM, van Duinen, SG, Smits, M, Taphoorn, MJ, French, P & van den Bent, M 2020, 'Survival of diffuse astrocytic glioma, IDH1/2 wildtype, with molecular features of glioblastoma, WHO grade IV: a confirmation of the cIMPACT-NOW criteria', Neuro-Oncology, vol. 22, no. 4, pp. 515-523. https://doi.org/10.1093/neuonc/noz200

Survival of diffuse astrocytic glioma, IDH1/2 wildtype, with molecular features of glioblastoma, WHO grade IV: a confirmation of the cIMPACT-NOW criteria. / Tesileanu, Mircea; Dirven, L; Wijnenga, Maarten; Koekkoek, JAF; Vincent, Arnaud ; Dubbink, Erik jan ; Atmodimedjo, Peggy ; Kros, J.M.; van Duinen, SG; Smits, Marion; Taphoorn, MJ; French, Pim ; van den Bent, Martin.

In: Neuro-Oncology, Vol. 22, No. 4, 2020, p. 515-523.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Survival of diffuse astrocytic glioma, IDH1/2 wildtype, with molecular features of glioblastoma, WHO grade IV: a confirmation of the cIMPACT-NOW criteria

AU - Tesileanu, Mircea

AU - Dirven, L

AU - Wijnenga, Maarten

AU - Koekkoek, JAF

AU - Vincent, Arnaud

AU - Dubbink, Erik jan

AU - Atmodimedjo, Peggy

AU - Kros, J.M.

AU - van Duinen, SG

AU - Smits, Marion

AU - Taphoorn, MJ

AU - French, Pim

AU - van den Bent, Martin

PY - 2020

Y1 - 2020

U2 - 10.1093/neuonc/noz200

DO - 10.1093/neuonc/noz200

M3 - Article

VL - 22

SP - 515

EP - 523

JO - Neuro-Oncology

JF - Neuro-Oncology

SN - 1522-8517

IS - 4

ER -